These results may seem contradictory initially, as instinctively, Tregs are recognized as immunosuppressive of CD8+ T cell anti-tumor immunity, and CD4+ Th17+ T-cells are pro-inflammatory [26]. The gene discussed is CD8A; the disease is neoplasm.